Dementia Discovery Fund
Specialist venture fund backing therapeutics for dementia, including Alzheimer's and Parkinson's.
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed, Series A, Series B+
- Sector focus
- Biotech & Life Sciences, Hardware & Robotics
- Cheque size
- Above €3M
- Fund size
- $600m+ across funds
- Founded
- 2015
- Website
- svhealthinvestors.com
The Dementia Discovery Fund is a venture fund dedicated to companies developing or enabling new treatments for dementia, including Alzheimer's, Parkinson's and frontotemporal dementia. It invests from target discovery through clinical development and also creates new biotech companies.
Established in 2015 and managed by SV Health Investors from London and Boston, it closed its first fund at £250m in 2018 and has raised over $600m in total from pharmaceutical companies, British Patient Capital, foundations and charities.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.